Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Luteolin: a flavonoid with a multifaceted anticancer potential
Parteek Prasher, Mousmee Sharma, Sachin Kumar Singh, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Oxidative Stress: The Role of Antioxidant Phytochemicals in the Prevention and Treatment of Diseases
Adele Muscolo, Mariateresa Oliva, Torello Giulio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3264-3264
Open Access | Times Cited: 90
Revisiting luteolin: An updated review on its anticancer potential
Abdur Rauf, Polrat Wilairatana, Payal B. Joshi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26701-e26701
Open Access | Times Cited: 17
Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
Enzo Pereira de Lima, Lucas Fornari Laurindo, Vitor Cavallari Strozze Catharin, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 124-124
Open Access | Times Cited: 4
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Gabriele De Rubis, Keshav Raj Paudel, Leander Corrie, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2793-2833
Closed Access | Times Cited: 29
Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches
Mingyi Shi, Zixian Chen, Hui Gong, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 880-911
Closed Access | Times Cited: 25
Application of Luteolin in Neoplasms and Nonneoplastic Diseases
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 22
Luteolin Alleviates Inflammation Induced by Staphylococcus aureus in Bovine Mammary Epithelial Cells by Attenuating NF-κB and MAPK Activation
Yingfang Guo, Jin‐Xin Zhang, Ting Yuan, et al.
Veterinary Sciences (2025) Vol. 12, Iss. 2, pp. 96-96
Open Access | Times Cited: 1
Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis
Maria Teresa Rocchetti, Francesco Bellanti, Mariia Zadorozhna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8824-8824
Open Access | Times Cited: 21
Reactive Oxygen Species and H. pylori Infection: A Comprehensive Review of Their Roles in Gastric Cancer Development
Dhiraj Kumar Sah, Archana Arjunan, Bora Lee, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1712-1712
Open Access | Times Cited: 17
Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool
Mohd Suhail, Wejdan M. AlZahrani, Shazi Shakil, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Harnessing Luteolin's therapeutic potential in human disorders: Medicinal significance, biological, clinical properties and analytical aspects
Abhishek Singh, Seema Yadav, Prateek Pathak, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100401-100401
Open Access | Times Cited: 5
Integrating UHPLC-Q-TOF-MS/MS, Network Pharmacology, Bioinformatics and Experimental Validation to Uncover the Anti-cancer Mechanisms of TiaoPi AnChang Decoction in Colorectal Cancer
Yantong Guo, Chunsheng Yuan, Ting Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118576-118576
Closed Access | Times Cited: 5
Comprehensive In Silico Analysis of Flavonoids in Breast Cancer Using Molecular Docking, ADME, and Molecular Dynamics Simulation Approach
Dheeraj Gupta, Kavita Apte, Puzhakkal Abhirami, et al.
Peptide Science (2025) Vol. 117, Iss. 1
Closed Access
Combination of Metabolomics and Bioinformatics to Reveal the Mechanism of Luteolin in the Treatment of Cervical Cancer
Dongming Cao, Yi-Ping Rao, Tao Liu, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Evaluating the therapeutic potential of 4-hydroxyflavanes diastereomers derivatives against (MetAP2) for anti-cancer therapy: a molecular docking study
Thinhinane Hamache, Nasser Belboukhari, Khaled Sekkoum, et al.
Chemical Product and Process Modeling (2025) Vol. 20, Iss. 1, pp. 101-110
Closed Access
Metabolic division engineering of Escherichia coli consortia for de novo biosynthesis of flavonoids and flavonoid glycosides
Zetian Qiu, Yumei Han, Jia Li, et al.
Metabolic Engineering (2025)
Closed Access
The Role of Luteolin in Inhibiting Prostaglandin‐Endoperoxide Synthase 2 to Relieve Neointimal Hyperplasia in Arteriovenous Fistula
Ruibin Zhang, Wei Li, Jihua Yang, et al.
Advanced Biology (2025)
Closed Access
Nanoparticle-based strategies with bioactive compounds for targeting oxidative stress in therapeutic interventions: A comprehensive review
Rekha Thiruvengadam, Benod Kumar Kondapavuluri, Lakshmi Thangavelu, et al.
Industrial Crops and Products (2025) Vol. 227, pp. 120804-120804
Open Access
Prunin: An Emerging Anticancer Flavonoid
Juie Nahushkumar Rana, Sohail Mumtaz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2678-2678
Open Access
Virtual Screening and Experimental Validation of Luteolin Cocrystals for Enhanced Solubility
Jia Xu, Hongjian Ji, Guozhe Zhang, et al.
Journal of Molecular Structure (2025), pp. 142207-142207
Closed Access
Study on the regulatory mechanism of luteolin inhibiting WDR72 on the proliferation and metastasis of non small cell lung cancer
Guanglin Shi, Jiacong Wei, Subi Rahemu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A Literature Review on the Antiviral Mechanism of Luteolin
Peng Lü, Tingrui Zhang, Yali Ren, et al.
Natural Product Communications (2023) Vol. 18, Iss. 4
Open Access | Times Cited: 11
Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
Katarzyna Jakimiuk, Łukasz Szoka, Arkadiusz Surażyński, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 487-487
Open Access | Times Cited: 4
TCM targets ferroptosis: potential treatments for cancer
Liwen Qin, Yuhan Zhong, Yi Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Luteolin Alleviates Oxidative Stress in Chronic Obstructive Pulmonary Disease Induced by Cigarette Smoke via Modulation of the TRPV1 and CYP2A13/NRF2 Signaling Pathways
Lina Zhou, Tunyu Jian, Yan Wan, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 369-369
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top